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Edited by Ulrike KutayAbstract In higher eukaryotes, the production of mature mes-
senger RNA that exits the nucleus to be translated into protein
requires precise and extensive processing of the nascent tran-
script. The processing steps include 5 0-end capping, splicing,
and 3 0-end formation. Pre-mRNA processing is coupled to tran-
scription by mechanisms that are not well understood but involve
the carboxyl-terminal domain (CTD) of the largest subunit of
RNA polymerase II. This review focuses on recent ﬁndings that
provide novel insight into the role of the CTD in promoting RNA
processing and surveillance.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The expression of human protein-coding genes is remark-
ably complex. The initial primary transcripts synthesized by
RNA polymerase II (pre-mRNAs) are extensively processed
before functional messenger RNAs exit the nucleus to be trans-
lated into protein in the cytoplasm. Pre-mRNA processing
steps include the addition of a 7-methyl guanosine (m7G)
cap at the 5 0-end, splicing of introns, and 3 0-end formation
by cleavage and polyadenylation (Table 1).
The vast majority of human pre-mRNAs contain up to 90%
of non-coding sequence that must be spliced. Excision of in-
trons with single nucleotide precision relies on the spliceosome
(Table 1), one of the largest and most elaborate macromolec-
ular machines in the cell [1–3]. The building blocks of the
spliceosome are uridine-rich small nuclear RNAs (U snRNAs)
packaged as ribonucleoprotein particles (snRNPs) that func-
tion in conjunction with over 200 distinct non-snRNP auxil-
iary proteins [4,5]. The major spliceosomal small nuclear
ribonucleoprotein particles are the Ul, U2, U5 and U4/U6
snRNPs. Each snRNP consists of one or two U snRNAs
(Ul, U2, U5 and U4/U6 snRNAs) bound by a protein complex
that comprises seven common Sm proteins and one or moreAbbreviations: CTD, Carboxyl-terminal domain of the largest subunit
of RNA Polymerase II; U snRNP, Uridine-rich small nuclear
ribonucleoprotein particle; ss, splice site; Py, pyrimidine; m7G,
7-methyl guanosine
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doi:10.1016/j.febslet.2008.04.019proteins speciﬁc to each snRNP. The selection of speciﬁc splice
sites (ss) on a particular pre-mRNA substrate relies on an intri-
cate interplay involving the cooperative binding of trans-acting
splicing proteins to cis-acting sequence elements in the pre-
mRNA. In mammals, an intron is deﬁned by four short and
poorly conserved consensus sequences: the exon–intron junc-
tions (5 0ss and 3 0ss); the branch point sequence; and the poly-
pyrimidine tract (Table 1). These sequences are recognized by
base pairing with the spliceosomal snRNAs (Fig. 1). In addi-
tion, both exons and introns contain weak binding sites for a
multitude of splicing auxiliary and regulatory proteins [6,7].
Unlike yeast genes, which contain few and short introns, an
average human gene consists of eight exons of 120 nucleo-
tides separated by introns at least 10 times longer in length
[8]. Accurate recognition of multiple small exons embedded
in large introns is thought to rely on a mechanism that involves
cross-exon pairing between the 5 0ss and 3 0ss [9]. According to
the ‘‘exon deﬁnition’’ model proposed by Berget, an interior
exon is ﬁrst recognized by the paired binding of Ul and U2
snRNPs and associated splicing factors to the 5 0ss and3 0ss, fol-
lowed by the juxtaposition of neighboring exons in the correct
order. The model further assumes that processing of the last
exon involves interaction between splicing components at the
3 0ss and the polyadenylation complex [10,11], whereas recogni-
tion of the ﬁrst exon in a pre-mRNA is thought to be mediated
by interactions of the nuclear cap-binding complex (CBC) with
the spliceosome [12]. Thus, capping, splicing and 3 0-end forma-
tion are intimately interconnected.2. Functional pairing of 5 0ss and 3 0ss occurs early in spliceosome
assembly
The biochemical reactions of pre-mRNA splicing involve
two transesteriﬁcation steps [13,14]. In the ﬁrst, the 2 0-OH of
the branch point adenosine is the nucleophile that attacks
the 5 0ss phosphate, resulting in a free 5 0 exon and a lariat inter-
mediate (Fig. 2). In the second step, the 3 0-OH of the 5 0 exon
attacks the 3 0ss, resulting in release of the intron and concom-
itant ligation of the two exons. A fundamental pre-requisite for
these reactions is the correct juxtaposition of branch point, 5 0ss
and 3 0ss nucleotides. Indeed, hydroxyl-radical probing, a tech-
nique used to investigate RNA neighborhoods, revealed that
the branch point and the 3 0ss are located within 20 A˚ of
the 5 0ss in the early stage of spliceosome assembly [15] (Fig.
3). More recently, the same technique was used to show that
nucleotides at the 5 0end of U2 snRNA are already positioned
near Ul and the functional sites of the pre-mRNA at theblished by Elsevier B.V. All rights reserved.
Table 1
Glossary
Pre-mRNA Precursor of mature messenger RNA, the primary transcript of a protein-coding gene that is synthesized by
RNA polymerase II
Exon Exons are the regions of the primary RNA transcript (or the DNA that encodes them) that are present in the
mature messenger RNA, which exits the nucleus and undergoes translation in the cytoplasm to produce
protein
Intron The term intron derives from ‘‘intragenic region’’. Introns are non-coding sections of an RNA or
corresponding gene that are not present in the mature messenger RNA. Introns are also called intervening
sequences
Pre-mRNA splicing The process by which introns are removed from the pre-mRNA and exons are ligated
Spliceosome The macromolecular machine composed of RNA and protein that is required for pre-mRNA splicing
U snRNPs Uridine-rich small nuclear ribonucleoprotein particles
5 0 and 3 0ss The 50 and 3 0 splice sites correspond to the two exon–intron junctions that mark the beginning and end of an
intron. They are also called splice donor and splice acceptor sites, respectively
Branch point During the splicing reaction, introns are removed as a lariat structure in which the 50 end of the intron is
joined to an adenosine located 17–40 nucleotides upstream of the 30 splice site. This A residue is called the
branch point because it forms a branch in the lariat structure
Py-tract Pyrimidine (py)-rich region of approximately 15 nucleotides near the 30ss, downstream of the branch point A
CTD Carboxyl-terminal domain of the largest subunit of RNA Polymerase II
SR proteins SR proteins are members of the serine/arginine-rich (SR) family of splicing factors. These proteins bind to
speciﬁc pre-mRNA sequences known as exonic splicing enhancers (ESEs)
m7G cap The 50-end of eukaryotic pre-mRNAs is modiﬁed by addition of a 7-methyl guanosine cap. The cap is bound
by the nuclear cap binding protein (CBP)
Cleavage The 3 0-terminus of a pre-mRNA is generally determined by endonucleolytic cleavage of the primary
transcript at a site situated several hundred bases downstream from a conserved signal sequence. In most
cases, cleavage is coupled to polyadenylation
Polyadenylation Polyadenylation is the covalent addition of a series of adenosine residues (the so-called poly(A) tail) to the
free 3 0-end of the RNA at the cleavage site
Fig. 1. Interactions between pre-mRNA, UlsnRNP and U2 snRNP early in the splicing process. The 5 0 region of Ul snRNA within the Ul snRNP
complex initially base-pairs with nucleotides at the 5 0 splice site (5 0ss). The U2 snRNA within the U2 snRNP complex base-pairs with a sequence that
includes the branch point A, which is not base-paired. The polypyrimidine (Py) tract and 3 0 splice site (3 0ss) are also indicated.
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able spliceosomal complex (the E complex) contains the Ul
snRNP, splicing factors U2AF65, U2AF35 and SF1, members
of the SR protein family and the U2 snRNP, which at this
stage is loosely associated. Subsequently, the U2 snRNP forms
an ATP-dependent stable interaction with the intron. In part,
this interaction involves base pairing of the U2 snRNA with
the branch point sequence and the adenosine nucleophile is se-
lected because it bulges out of from this duplex [17]. Following
recruitment of the U4/U6.U5 tri-snRNP to the spliceosome,
the U6 snRNA establishes base pairing interactions with the
5 0 end of the U2 snRNA, and the resulting U2/U6 snRNA
structure forms the catalytic center of the spliceosome.
According to the data from Donmez et al. [16], the catalytically
important 5 0 terminal nucleotides of U2 snRNA are immedi-
ately positioned in close proximity to the reactive sites in the
pre-mRNA (Fig. 3).How the U2 snRNA holds steady in the position for its sub-
sequent base pairing with the branch point sequence while the
U2 snRNP is still loosely associated with the E complex? What
bridges the two ends of an intron before the stable association
of U2 snRNP to the pre-mRNA? Although there are no deﬁn-
itive answers to these questions, it is currently assumed a mul-
titude of weak protein–RNA and protein–protein interactions
play a key role in the 3D architecture of a spliceosome assem-
bled on pre-mRNA. Namely, the U2 snRNP may associate
with the branch point region via RNA contacts established
by its subunits SF3a and SF3b, and/or by protein–protein
interaction with U2AF65 bound to the nearby polypyrimide
tract [18]. Moreover, members of the serine/arginine-rich
(SR) family of splicing factors (see below) facilitate interac-
tions between proteins bound across the intron [19–23]. Addi-
tional evidence points to a role of the carboxyl-terminal
domain of the largest subunit of RNA polymerase II (CTD)
Fig. 2. The chemistry of pre-mRNA splicing. The splicing reaction consists of two consecutive transesteriﬁcation (replacement of one phosphodiester
linkage for another) events. The ﬁgure depicts the result of the ﬁrst step: 5 0 splice site cleavage and lariat formation. In the second step, the 3 0-OH of
the 5 0 exon attacks the phosphodiester bond (–p) at the 3 0ss, resulting in release of the intron and concomitant ligation of the two exons.
Fig. 3. Structural organization of the pre-mRNA at the earliest stage of spliceosome assembly. The functional sites of the pre-mRNA, i.e. the 5 0
splice site, branch point sequence, and 3 0 splice site, are in close spatial proximity. Bending of the polypyrimidine tract induced by interaction with
U2AF brings the 3 0 splice site into juxtaposition with the branch point sequence. Both the 5 0 and 3 0 splice sites are close to the 5 0-end of the U2
snRNA, which later assembles with U6 snRNA forming the catalytic center of the spliceosome.
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following section.3. Cotranscriptional tethering: a clamp to hold adjoining exons?
Ample evidence from a series of biochemical and cytologi-
cal experiments demonstrates that splicing is tightly coupled
to transcription and at least some introns are excised while
the nascent transcript is still associated with the gene (for a
comprehensive recent review see [24]). Not only splicing, but
also capping and 3 0-end formation are coupled to transcrip-
tion. This is achieved by recruitment of essential processing
factors to the CTD of the largest subunit of RNA pol II
[25]. Unlike all other DNA-dependent RNA polymerases,
eukaryotic pol II contains a unique CTD that is highly con-
served through evolution, increasing in length and diversifying
in structure with the complexity of organisms [26]. In yeast,
the CTD consists of 26–29 repeats of a conserved heptapep-
tide with the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-
Pro6-Ser 7. The mammalian CTD has 52 repeats, of which
21 obey the conserved consensus but the remainder displays
a variety of substitutions mostly located in the C-terminal
part. At the very C-terminus, the mammalian CTD further
comprises a speciﬁc 10 amino acid motif. The CTD is themajor site of reversible pol II phosphorylation. Five out of
the seven consensus residues can be phosphorylated, but res-
idues Ser2 and Ser5 are the main targets of phosphorylation.
RNA polymerase II with hypophosphorylated CTD is re-
cruited to the preinitiation complex and generates short tran-
scripts by non-processive transcription [27]. Phosphorylation
of Ser5 residues occurs at or near the promoter and correlates
with transcription initiation and early elongation (promoter
clearance), whereas Ser2 phosphorylation associates with eﬃ-
cient transcript elongation [28].
Truncation of the CTD causes defects in splicing in vivo [29–
31] and puriﬁed pol II or the CTD itself activates splicing in
vitro [32,33]. However, the CTD only stimulated the splicing
of pre-mRNAs that contained complete exons with both 3 0ss
and 5 0ss. This led to the speculation that the CTD may immo-
bilize consecutive exons, thereby facilitating their juxtaposition
[33]. Direct experimental support to this model was recently re-
ported by Proudfoot and co-workers [34]. The authors investi-
gated the splicing of pre-mRNAs containing an intron
engineered to be cotranscriptionally cleaved. Disrupting the
continuity of the nascent RNA had no eﬀect on splicing of
the exons that ﬂanked the cleaved intron. These results imply
that newly transcribed consecutive exons are somehow teth-
ered to the transcription complex until they are spliced to-
gether [34].
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tethering?
Binding of processing factors to the CTD increases their
concentration in the vicinity of the nascent transcript, facilitat-
ing a short ‘‘molecular hop’’ to the pre-mRNA as the target se-
quences emerge from the polymerase [35]. Many proteins have
been described to bind to the CTD, including regulators of
transcription initiation, histone methyltransferases, the pre-
mRNA capping enzyme guanylyltransferase and factors in-
volved in pre-mRNA 3 0-end cleavage and polyadenylation
[36].
In a recent proteomic analysis of immunopuriﬁed human
RNA polymerase II, Reed and co-workers identiﬁed SR pro-
teins and all of the components of the Ul snRNP, but no other
snRNPs or splicing factors [37]. Consistent with this result,
several previous studies had reported that a subset of the SR
proteins show preferential binding to the phosphorylated
CTD [38–41]. SR proteins are a highly conserved family of
essential splicing factors that share a bipartite structure com-
posed of an N-terminal RNA binding domain and a C-termi-
nal arginine–serine-rich domain. SR proteins bind to speciﬁc
exonic sequence elements (ESEs) and play a key role in recog-
nizing splicing signals and promoting spliceosome assembly
[22,42]. It is therefore conceivable that the Ul snRNP and
SR proteins pre-loaded onto the CTD [37] bind to the nascent
transcript as the5 0ss and ESE sequences emerge from the poly-
merase (Fig. 4). Assuming that SR proteins bridge their exonic
binding sites to the CTD, SR proteins may provide the molec-
ular ties that tether adjoining exons to RNA pol II as recently
reported by the Proudfoot laboratory [34]. Consistent with this
view, binding of SR proteins to ESEs was previously shown to
play a critical role in ensuring the correct 5 0 to 3 0 linear order
of exon joining during splicing [43], and the CTD was foundFig. 4. Binding of Ul snRNP and SR proteins to the CTD promotes rapid
laboratory indicate that Ul snRNP and SR proteins associate with RNA pol I
recognition of the 5 0 splice site by Ul snRNA, as well as the eﬃcient recruitm
proteins (depicted in red) may thus act as clamps that hold adjoining exonsrequired to mediate the eﬀect of an SR protein on alternative
exon inclusion [44].5. Checkpoints in mRNA biogenesis
The modiﬁcation of the 5 0 ends of nascent RNA polymerase
II transcripts by the addition of a m7G cap is the ﬁrst pre-
mRNA processing event in all eukaryotic cells. The cap is
added when the transcript is 25 bases long, soon after its
5 0 end emerges from the exit channel of the polymerase. The
reaction is catalyzed by the capping enzyme bound to the
phosphorylated CTD. It is believed that after initiation of
transcription, while the CTD is phosphorylated at Ser-5, a neg-
ative elongation factor (NELF) is recruited through binding to
DRB sensitivity-inducing factor, DSIF [45]. This causes the
arrest of the transcription complex before it enters into pro-
ductive elongation, giving ample time for capping. Most inter-
estingly, the capping enzyme interacts with both Ser-5
phosphorylated CTD and DSIF, and its recruitment disables
NELF-mediated repression of transcription [46]. This suggests
that the capping enzyme plays a critical checkpoint role during
promoter clearance [46]. More recent data provides further
support to this ‘‘checkpoint model’’ ensuring that uncapped
transcripts are not elongated [47]. Guiguen and colleagues
showed that depletion of the ﬁssion yeast cap-methyltransfer-
ase compromised the activity of Cdk9-Pchl (the kinase com-
plex that favors CTD phosphorylation on Ser2), resulting in
promoter-proximal pol II stalling [47].
Another point of coordination in mRNA biogenesis is the
formation of pre-mRNA 3 0-ends. The 3 0-end of all eukaryotic
mRNAs, with the exception of the replication-dependent
histone-encoding transcripts, consists of a tail of adenosine
residues. Poly(A) tails are added by a template-independentcotranscriptional spliceosome assembly. Recent data from the Reed
I, possibly to the CTD [37]. This may increase the ﬁdelity of the earliest
ent of SR proteins to exonic splicing enhancers (ESEs). The bound SR
tethered to the polymerase [34].
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site in the 3 0-end of the pre-mRNA that is speciﬁed by con-
served sequence elements [48]. The cleavage and polyadenyla-
tion machinery consists of a number of proteins that together
recognize the poly(A) site, cleave the transcript and add the
poly(A) tail. Some of these proteins bind directly to the
CTD, preferentially to repeats phosphorylated on Ser-2
[49,50]. In mammals, as well as in yeast, defects in pre-mRNA
3 0-end formation cause accumulation of aberrant transcripts
near the site of transcription [51,52]. It was therefore proposed
that release of a nascent transcript from the site of transcrip-
tion may be a checkpoint for mRNA integrity [53]. Evidence
for an involvement of the CTD on mRNA release from the
transcription site is provided by the ﬁnding that a truncated
CTD containing 31 repeats (heptads 1–23, 36–38 and 48–52)
is suﬃcient to support transcription, splicing, cleavage and
polyadenylation. Yet, the resulting mRNAs are mostly re-
tained in the vicinity of the gene after transcriptional shutoﬀ
[54]. Possibly, the missing heptads in the truncated CTD mu-
tant are required for binding of proteins implicated in a ﬁnal
co-transcriptional maturation of spliced and 3 0 end cleaved
and polyadenylated mRNAs into export-competent ribonu-
cleoprotein particles. It is further conceivable that this defect
in production of fully mature mRNA activates a quality con-
trol checkpoint or surveillance mechanism that prevents diﬀu-
sion of mRNPs to the nuclear pores by tethering them near the
gene template, with stalled mRNA being subsequently de-
graded by the exosome present at the transcription site [54].
The exosome is a complex of exoribonucleases that progres-
sively digest RNAs from the 3 0-end and play a central role in
nuclear mRNA surveillance [55]. The exosome was initially
identiﬁed and characterized in the budding yeast Saccharomy-
ces cerevisiae but is conserved in all eukaryotes analyzed. The
yeast exosome is present in the nucleus, nucleolus and cyto-
plasm, and is comprised of ten ‘‘core’’ subunits all of which
are essential for viability. An additional exonuclease, Rrp6,
associates exclusively with the nuclear exosome [55]. In the ab-
sence of Rrp6 in yeast, aberrant pre-mRNAs are no longer re-
tained at the transcription site [52,56,57]. In Drosophila , Rrp6
interacts directly with the transcription elongation factor Spt6
[58], and in mammals Spt6 binds to Ser-2 phosphorylated
polymerase [59]. Human Spt6 interacts with the Iwsl protein,
and depletion of endogenous Iwsl reduces recruitment of
Rrp6 to nascent transcripts and produces mRNA processing
and export defects [59]. Thus, Spt6 connects transcription elon-
gation with mRNA surveillance via the CTD.6. Concluding remarks
Recent progress in understanding the complex coordination
of orderly events that produce mature mRNA in eukaryotes
discloses striking similarities with cell-cycle progression, where
completion of one step enables the onset of the following stage.
Coupling between transcription, mRNA processing and
mRNA surveillance avoids the wasteful production of non-
functional mRNAs with potentially deleterious eﬀects for the
cell. While the checkpoint model remains speculative, the
CTD emerges as a master coordinator capable of communicat-
ing with a wide range of molecular pathways, from histone
methylation to RNA capping, 3 0-end formation, splicing,
transport and degradation. The physiological importance ofkeeping mRNA biogenesis under tight quality control is well
illustrated by the growing number of human diseases known
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